The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005)
Key result
This letter highlights discrepancies in the 2005 ESC guidelines for chronic heart failure regarding the recommendations for aldosterone receptor antagonists and angiotensin receptor blockers.
Population
Patients with chronic heart failure, specifically discussing NYHA class I-II post-myocardial infarction or…
Design
Editorial
Authors
Discussion
Loading...
Member takes
Implication
Highlights inconsistencies in the 2005 ESC heart failure guidelines regarding the specific indications and timing for aldosterone antagonists and ARBs.
Structured PICO
P
Population
Patients with chronic heart failure, specifically discussing NYHA class I-II post-myocardial infarction or with established chronic heart failure
I
Intervention
Aldosterone receptor antagonists and Angiotensin receptor blockers (ARBs)
Highlights inconsistencies in the 2005 ESC heart failure guidelines regarding the specific indications and timing for aldosterone antagonists and ARBs.
Cite This Study
Henry Krum (2005) conducted a letter in chronic heart failure. This letter highlights discrepancies in the 2005 ESC guidelines for chronic heart failure regarding the recommendations for aldosterone receptor antagonists and angiotensin receptor blockers.